FDA issues final Nanomaterials Guidance for Industry (Cell and Gene Therapy Catapult – Regulatory Round-up – April 2022)
The FDA has issued on 21st of April 2022 the finalised version of the document Guidance for Industry: Drug Products, Including Biological Products, that Contain Nanomaterials.
See all of Catapult’s Regulatory Round-up for April 2022 here. Published on the 29th of April 2022.
OpenEdition vous propose de citer ce billet de la manière suivante :
adelage (3 août 2022). FDA issues final Nanomaterials Guidance for Industry (Cell and Gene Therapy Catapult – Regulatory Round-up – April 2022). ELSIBI. Consulté le 12 janvier 2026 à l’adresse https://doi.org/10.58079/o61u





